Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
3
×
new york top stories
biotech
boston blog main
boston top stories
national
new york blog main
novartis
roche
san francisco top stories
abbvie
abeona therapeutics
accent therapeutics
achilles therapeutics
acorda therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
ampyra
apokyn
apomorphine
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
billy dunn
biogen
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
What
drug
3
×
new
3
×
patients
3
×
approved
fda
friday
acorda
advantages
atrophy
bar
bio
brings
cope
daily
disease
episodes
evrysdi
expect
gamble
gets
green
help
home
intended
late
lights
liquid
looms
market
meant
medco’s
medications
medicine
mover
muscular
nod
oral
parkinson’s
payers
physicians
Language
unset
Current search:
drug
×
patients
×
new
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms